Literature DB >> 20720427

Association of hospital arrival time with modified rankin scale at discharge in patients with acute cerebral infarction.

Young Dae Kwon1, Sung Sang Yoon, Hyejung Chang.   

Abstract

This study evaluated the time interval from the development or recognition of a symptom to hospital arrival and investigated its association with the modified Rankin Scale (mRS) at discharge in patients with acute cerebral infarction. A registry was established with ischemic stroke patients admitted to an academic medical center in Korea from January 2005 to March 2009. The time interval between symptom onset and hospital arrival was recorded for each patient and analyzed along with the patient's clinical characteristics and mRS at discharge. Regardless of initial severity at admission, mRS was significantly different between two groups of hospital arrival: within 3 h and beyond 3 h. Multiple regression analysis also showed more positive mRS scores for patients within the 3-hour arrival, controlling for other significant factors. The findings provided patients' initiatives for early hospital arrival.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20720427     DOI: 10.1159/000319176

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

1.  Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction.

Authors:  Zhi-Jian Lin; Hong-Yan Qiu; Xiao-Xin Tong; Yi Guo; Man-Fu Han; Chun-Shui Yang; Kai-Hua Lin; Jun Wu; Xing Li; Yang Yang
Journal:  Biosci Rep       Date:  2018-01-17       Impact factor: 3.840

2.  Impact of onset-to-door time on outcomes and factors associated with late hospital arrival in patients with acute ischemic stroke.

Authors:  Eung-Joon Lee; Seung Jae Kim; Jeonghoon Bae; Eun Ji Lee; Oh Deog Kwon; Han-Yeong Jeong; Yongsung Kim; Hae-Bong Jeong
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.